Stocks Consumer discretionary NUTX
NASDAQ · Consumer discretionaryNutex Health Inc. (NUTX)
Nutex Health Inc. brought in $796.5M of revenue over the twelve months to September 30, 2026, down 18.8% from a year earlier. Net income was $164.7M, a net margin of 20.7%. Operating cash flow minus capital spending left $245.6M of free cash flow in fiscal 2025. At September 30, 2026 it held $249.9M in cash against $42.3M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 5, 2026.
Key facts about Nutex Health Inc.
- Net worth
- Nutex Health Inc. has a market value (market cap) of $1.3B at the latest share price, and shareholders' equity of $435.6M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $875.3M (+82.4% year on year), with net income of $70.8M. Over the 12 months to September 30, 2026: revenue $796.5M, net income $164.7M.
- Cash flow
- In fiscal 2025 operations brought in $248.1M of cash; after $2.5M of capital spending, free cash flow was $245.6M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 5, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Nutex Health Inc.'s next report is expected around March 4, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Nutex Health Inc. does
Nutex Health Inc. is registered with the SEC under industry code SIC 7389 (Services-Business Services, NEC). Its shares trade on NASDAQ under the ticker NUTX.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $875.3M | $70.8M | $10.48 | $245.6M |
| 2024 | $479.9M | $52.1M | $9.69 | $20.8M |
| 2023 | $247.6M | -$45.8M | -$10.39 | -$8.2M |
| 2022 | $219.3M | -$424.8M | -$100.36 | $36M |
| 2021 | $331.5M | $132.6M | $32.95 | $136.5M |
| 2020 | $274M | $106M | $26.96 | $25.5M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where NUTX ranks in Consumer discretionary
Latest SEC filings
What Nutex Health Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 5, 2026
- November 5, 2026Quarterly report 10-Q · period to September 30, 2026Revenue fell 19% to $217.6M versus the same quarter last year; diluted EPS $5.71 versus $7.76.
- September 11, 2026Other event 8-K
- August 31, 2026
- August 24, 2026Other event 8-K
- August 13, 2026Other event 8-K
- August 6, 2026
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 14% to $210.8M versus the same quarter last year; diluted EPS $9.38 versus -$2.95.
- July 21, 2026
- May 7, 2026Passive stake changed SCHEDULE 13G/A
What is NUTX worth? A DCF from its reported cash flow
Insider trades
What the people running Nutex Health Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $43.5K worth of shares in the last 90 days and bought none on the open market.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 18, 2026 | Saunders Scott JDirector | Sold | 203 | $43.5K |
| July 31, 2026 | Jaumot Frank EDirector | Exercised options | 603 | - |
| July 31, 2026 | Grenas Cheryl YvonneDirector | Exercised options | 603 | - |
| July 31, 2026 | Reed Michael LeeDirector | Exercised optionsindirect | 603 | - |
| July 31, 2026 | Saunders Scott JDirector | Exercised options | 603 | - |
| June 4, 2026 | Spears KelvinDirector | Other change | 2,519 | - |
| May 28, 2026 | Vo Thomas T.Chief Executive Officer, Director | Other changeindirect | 75,747 | - |
| April 9, 2026 | Vo Thomas T.Chief Executive Officer, Director | Other changeindirect | 184,071 | - |
Who owns NUTX
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Topline Capital Management, LLC13G, passive with 2 related filers | 9.9% | October 29, 2025 |
| Pertento Partners LLP13G, passive with 3 related filers | 5.9% | May 7, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 154 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Pertento Partners LLP | 451,310 | +77,340 |
| BlackRock, Inc. | 407,349 | +27,994 |
| American Century Companies Inc | 237,414 | +33,964 |
| Vanguard Capital Management LLC | 215,919 | -3,212 |
| Geode Capital Management, LLC | 132,049 | +9,936 |
| State Street Corp | 130,836 | +7,659 |
| D. E. Shaw & Co., Inc. | 97,454 | new |
| UBS Group AG | 77,912 | +8,342 |
| Winmill & Co. Inc | 65,350 | 0 |
| Focus Partners Wealth | 60,881 | new |
| Millennium Management LLC | 52,107 | -37,464 |
| Goldman Sachs Group Inc | 51,244 | +17,449 |
| Bridgeway Capital Management, LLC | 46,924 | +31,904 |
| Empowered Funds, LLC | 45,177 | +12,726 |
| Northern Trust Corp | 44,056 | +2,789 |
| Topline Capital Management, LLC | 41,764 | -136,036 |
| One Plus One Wealth Management, LLC | 40,441 | 0 |
| Vanguard Fiduciary Trust Co | 35,969 | +141 |
| Vanguard Portfolio Management LLC | 34,660 | -5,143 |
| Victory Capital Management Inc | 29,190 | -15,944 |
Insiders
11 insiders reported holding 2,243,717 shares in total, about $417.9M at the last price.
| Holder | Shares |
|---|---|
| Vo Thomas T.Chief Executive Officer, Director | 2,103,0142,103,014 held indirectly |
| Chang Michael L.Chief Medical Officer | 82,35682,356 held indirectly |
| Spears KelvinDirector | 34,656 |
| Bates Jon ChristianChief Financial Officer | 8,305 |
| Hosseinion WarrenPresident, Director | 7,765 |
| Montgomery Pamela W.Chief Legal Officer-Healthcare | 2,758 |
| Luqman Elisa VChief Legal Officer - SEC | 2,3702,370 held indirectly |
| Jaumot Frank EDirector | 753 |
| Reed Michael LeeDirector | 670670 held indirectly |
| Grenas Cheryl YvonneDirector | 670 |
Questions about NUTX
What does Nutex Health Inc. do?
Nutex Health Inc. is a company in the Consumer discretionary sector, listed on NASDAQ as NUTX. Its shares trade on NASDAQ under the ticker NUTX.
What is Nutex Health Inc.'s net worth?
Nutex Health Inc. has a market value (market cap) of $1.3B at the latest share price, and shareholders' equity of $435.6M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Nutex Health Inc. profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $164.7M on revenue of $796.5M, a net margin of 20.7%.
How much revenue does Nutex Health Inc. make?
Over the twelve months to September 30, 2026 Nutex Health Inc. reported revenue of $796.5M. That is 18.8% less than a year earlier.
When did Nutex Health Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 5, 2026. It covers the period to September 30, 2026.
When is Nutex Health Inc.'s next earnings report?
Nutex Health Inc.'s next report is expected around March 4, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare NUTX with
Follow NUTX
Get an email when Nutex Health Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Nutex Health Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.